{"id":"https://openalex.org/W433550048","doi":"https://doi.org/10.1201/9780203997048","title":"The Pharmaceutical Regulatory Process","display_name":"The Pharmaceutical Regulatory Process","alternate_titles":[],"publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W433550048","doi":"https://doi.org/10.1201/9780203997048","mag":"433550048"},"language":"en","primary_location":{"id":"doi:10.1201/9780203997048","doi":"https://doi.org/10.1201/9780203997048","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9780203997048","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["CRC Press","Taylor & Francis","Informa"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"book"},"parent_works":[],"lineage":["https://openalex.org/W433550048"],"child_works_count":39,"type":"book","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.4961000084877014,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.4961000084877014,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.4603999853134155,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.9660000205039978},{"id":"https://openalex.org/keywords/federal-food-drug-and-cosmetic-act","display_name":"Federal Food, Drug, and Cosmetic Act","score":0.8019999861717224},{"id":"https://openalex.org/keywords/new-drug-approvals","display_name":"new drug approvals","score":0.8460000157356262},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.781000018119812},{"id":"https://openalex.org/keywords/hatch-waxman-act","display_name":"Hatch-Waxman Act","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antibiotic-regulation","display_name":"antibiotic regulation","score":0.9100000262260437},{"id":"https://openalex.org/keywords/new-drug-application","display_name":"new drug applications","score":0.8209999799728394},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.8059999942779541},{"id":"https://openalex.org/keywords/current-good-manufacturing-practice","display_name":"current good manufacturing practice","score":0.9459999799728394},{"id":"https://openalex.org/keywords/usp","display_name":"USP","score":0.7599999904632568},{"id":"https://openalex.org/keywords/common-technical-document","display_name":"Common Technical Document","score":0.6800000071525574},{"id":"https://openalex.org/keywords/21-cfr-part-11","display_name":"21 CFR Part 11","score":0.9909999966621399},{"id":"https://openalex.org/keywords/over-the-counter-drugs","display_name":"over-the-counter drugs","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.549400269985199},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.41205504536628723},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3567247688770294},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.339290589094162},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.05079963803291321}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9780203997048","doi":"https://doi.org/10.1201/9780203997048","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9780203997048","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["CRC Press","Taylor & Francis","Informa"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"book"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1964679810","https://openalex.org/W4309043692","https://openalex.org/W4410785146","https://openalex.org/W999278634","https://openalex.org/W4240875855","https://openalex.org/W2769516268","https://openalex.org/W1523340844","https://openalex.org/W2490165140","https://openalex.org/W2804744315","https://openalex.org/W7070705916"],"abstract_inverted_index":{"Pharmaceutical":[0,88],"Regulation":[1,20],"Before":[2,15],"and":[3,8,16,42,52,55,64,107,130,151,154,163],"After":[4,17],"the":[5,70,77,108,122,125],"Food,":[6],"Drug,":[7],"Cosmetic":[9],"Act.":[10,46],"New":[11,84,94],"Drug":[12,25,34,43,72,85,95,109,126],"Approval":[13,26,35,78,91,98,110,127,162],"Process:":[14,27,36],"1962.":[18],"FDA":[19],"of":[21,69,92,99,121,135,159,165],"Biological":[22],"Products.":[23],"Generic":[24,31,33,56,101],"Pre-1984":[28],"History":[29],"Concerning":[30],"Drugs.":[32,137,170],"Post":[37],"1984:":[38],"Waxman-Hatch":[39],"Reform.":[40],"Food":[41],"Administration":[44],"Modernization":[45],"FDA's":[47],"Antibiotic":[48],"Regulatory":[49,114,143],"Scheme:":[50],"Then":[51],"Now.":[53],"Pioneer":[54],"Drugs:":[57],"Balance":[58],"Between":[59],"Product":[60],"Life":[61],"Cycle":[62],"Extension":[63],"Anti-Competitive":[65],"Behavior.":[66],"The":[67,119,157],"Influence":[68,120],"Prescription":[71],"User":[73],"Fee":[74],"Act":[75],"on":[76,124],"Process.":[79,111,128],"Clinical":[80],"Research":[81],"Requirements":[82],"for":[83],"Applications.":[86],"Active":[87],"Ingredients.":[89],"Obtaining":[90,97],"a":[93,100],".":[96],"Drug.":[102],"Current":[103],"Good":[104],"Manufacturing":[105],"Practice":[106],"CMC":[112],"Post-Approval":[113],"Affairs:":[115],"Constantly":[116],"Managing":[117],"Change.":[118],"USP":[123],"Ways":[129],"Means":[131],"to":[132],"U.S.":[133],"Registration":[134],"Foreign":[136],"Common":[138],"Technical":[139],"Document-Quality":[140],"(M4-Q):":[141],"One":[142],"Participant's":[144],"Perspective.":[145],"21":[146],"CFR":[147],"Part":[148],"11:":[149],"Compliance":[150],"Beyond.":[152],"Marketing":[153,164],"Advertising":[155],"Promotion:":[156],"Impact":[158],"Government":[160],"Regulations.":[161],"Nonprescription":[166],"or":[167],"OTC":[168],"Human":[169]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W433550048","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
